KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Assets Average (2016 - 2025)

Novavax has reported Assets Average over the past 15 years, most recently at $1.2 billion for Q4 2025.

  • Quarterly results put Assets Average at $1.2 billion for Q4 2025, down 28.0% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 28.0% YoY), and the annual figure for FY2025 was $1.4 billion, down 18.49%.
  • Assets Average for Q4 2025 was $1.2 billion at Novavax, down from $1.3 billion in the prior quarter.
  • Over the last five years, Assets Average for NVAX hit a ceiling of $2.7 billion in Q2 2022 and a floor of $1.2 billion in Q4 2025.
  • Median Assets Average over the past 5 years was $1.7 billion (2023), compared with a mean of $1.9 billion.
  • Biggest five-year swings in Assets Average: soared 736.45% in 2021 and later plummeted 40.86% in 2023.
  • Novavax's Assets Average stood at $2.6 billion in 2021, then fell by 11.99% to $2.3 billion in 2022, then dropped by 23.67% to $1.7 billion in 2023, then dropped by 5.26% to $1.6 billion in 2024, then fell by 28.0% to $1.2 billion in 2025.
  • The last three reported values for Assets Average were $1.2 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025) per Business Quant data.